GENINUS, Inc. is engaged in the research and development of NGS (Next Generation Sequencing)-based genome analysis technology, development and manufacturing of genome analysis solutions. The company was founded on April 20, 2018 and is headquartered in Seoul, South Korea.

Zhejiang Kunlong Technology Co., Ltd., established on 2021-07-22, Business scope includes general items:Medical Research and Experimental Development;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Machinery sales;Hardware retail;Specialty Chemicals Sales(Free of Hazardous Chemicals);Domestic trade agent;electronics sales;Conference and Exhibition Services;Information Consulting Service(Not including licensing information consulting services);Intellectual Property Services(Except for patent agency services);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;New material technology promotion service;Drug testing equipment sales;Experimental analysis instrument sales;Cosmetics Wholesale;Cosmetics Retail;Technology Import and Export;Import and export;Healthy food(prepackaged)Sales;Disinfectant sales(Free of Hazardous Chemicals);General Equipment Repair;Special Equipment Repair;Instrument Repair;Furniture Installation and Repair Services;electrical equipment repair;Computer and Office Equipment Repair;electronic,Mechanical equipment maintenance(No special equipment);Household Appliances Repair;Professional cleaning,to clean,Disinfection service;Health Supplies(non food)Sales;Machinery and Equipment Leasing;Special equipment rental;Office equipment rental service;rental service(Licensed rental services not included);Class I Medical Device Leasing;Class II Medical Device Leasing(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Inspection and testing service;Class III medical device business;Disinfection equipment sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Shenzhen Mercer Biomedical Technology Development Co., Ltd., established on 2014-04-03, Business scope includes general business items:Sales of Class I medical supplies and equipment;Technical development of biological products;Technology development of biotechnology products;Domestic Trade(Does not contain franchise,Exclusive control,Monopoly);working in information technology,electronic product,Biotechnology,Chemical Products,Building materials,Technical development of machinery and equipment,technical consulting,Technical Services,technology transfer.,The licensing program is:Operation of Class II Medical Devices.

Zhejiang Yihui Biotechnology Co., Ltd., established on 2017-12-08, Business scope includes general items:Engineering and Technology Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;New material technology promotion service;Experimental analysis instrument sales;Cosmetics Wholesale;Health Supplies(non food)Sales;Disinfectant sales(Free of Hazardous Chemicals);Specialty Chemicals Sales(Free of Hazardous Chemicals);Personal Hygiene Sales;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Non-residential real estate leases;property management;Conference and Exhibition Services;Information Consulting Service(Not including licensing information consulting services);business management(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Inspection and testing service;Class III medical device business;Drug Wholesale;Disinfection equipment sales;food sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Guangzhou Fuda Cancer Hospital is a tertiary specialized cancer hospital which is affiliated with the Health Department of Guangdong Province in China. It was designated a national key clinical (cancer) hospital by the National Health and Family Planning Commission in 2011. The same year, Guangzhou Fuda Cancer Hospital was honored with National Trustworthy Private Hospital by the National Institute of Hospital Administration. In 2012, China Hospital Association rated Guangzhou Fuda Cancer Hospital as China Public Confidence Model Hospital. It was accredited by JCI in 2014.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.